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Abstract: Studies have been conducted in order to identify the main factors that contribute to 
the development of obesity. The role of genetics has also been extensively studied. However, 
the substantial augmentation of obesity prevalence in the last 20 years cannot be justified only 
by genetic alterations that, theoretically, would have occurred in such a short time. Thus, the 
difference in obesity prevalence in various population groups is also related to environmental 
factors, especially diet and the reduction of physical activity. These aspects, interacting or 
not with genetic factors, could explain the excess of body fat in large proportions worldwide. 
This article will focus on positive energy balance, high-fat diet, alteration in appetite control 
hormones, insulin resistance, amino acids metabolism, and the limitation of the experimental 
models to address this complex issue.
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Introduction
Evidence suggests that overweight and obesity prevalence have been arising at alarming 
rates, both in developing and developed countries. Nearly two-thirds of the adult 
American population, for example, is already overweight or obese.1
Obesity is considered pandemic, as described by the World Health Organization.2,3 
In Brazil, the demographic, economical, and epidemiological changes that took 
place (intense urbanization process, increased penetration of “western culture,” and 
globalization, resulting in unfavorable diet and physical activity habits, especially 
among the poor) in recent years have led to a transition in nutritional patterns: reduction 
of malnutrition and augmentation of obesity cases.4–7
The first, second, and third National Health and Nutrition Examination Surveys 
(NHANES),8 conducted in the United States during the years 1971–1974, 1976–1980, 
and 1988–1991, respectively, showed that in spite of the USD33 million spent by the 
“weight loss” industry, the number of obesity cases has been rising significantly, with no 
differences in race and social status. In NHANES II, 25.4% of the adults were considered 
to be beyond ideal weight (body mass index .27.5 kg/m2); in NHANES III this percentage 
reached 33.3%;8 in NHANES 1999–2000, this percentage was more than 64%, which 
was maintained during another study conducted between 2001–2002.9
The consequences of obesity to one’s health are many and range from a higher risk 
of premature death to severe nonlethal disease (comorbidities) associated to it. Obesity 
is frequently related to hyperlipidemia10–12 and to type 2 diabetes,12 two conditions 
intimately related to cardiovascular diseases.13–15
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Ever since complications of obesity to health have been 
demonstrated, many studies have been conducted in order 
to identify the main factors that contribute to its develop-
ment. The role of genetics in the etiology of obesity has 
also been extensively analyzed. The identification and 
sequence of the ob gene, which encodes the peptide leptin, 
and the finding that a simple impairment in this gene seems 
to be the main cause of obesity in ob/ob rats16 have raised 
the interest in obesity genetics. However, the substantial 
augmentation of obesity prevalence in the last 20 years 
cannot be justified by genetic alterations that, theoretically, 
would have occurred in such a short time.17,18 Thus, some 
authors emphasize that the difference in obesity prevalence 
in various population groups is related to environmental 
factors,18,19 especially diet2,19–21 and the reduction of physi-
cal activity.2,3,19,20,22–24 The aim of this review is to correlate 
these aspects both in humans and in experimental models, 
whether or not interacting with genetic factors, in order to 
try to explain the excess of body fat in large proportions 
worldwide.25,26
Obesity-inducing factors
Energy balance
Positive energy balance is an important etiology factor to 
obesity development, by promoting augmentation in energy 
storage and body weight.27,28 Results obtained by the authors’ 
group demonstrated a high sedentary rate in obese subjects. 
In this study, 80% of the participants did not do any physical 
activity.29 In addition, modernization and the economic 
transition featured in most countries have enhanced processed 
food intake, which leads to high protein and hyperlipidic 
diets, and a reduction of complex carbohydrate content.30 
This dietary pattern also seems to be repeating in countries 
such as Brazil. Studies conducted by the authors’ group with 
obese Brazilian women showed that more than 30% of total 
caloric intake of this group had been provided by lipids,31–35 
which characterizes a dietary pattern similar to that featured 
in developed western countries.
In line with this, sedentary life and nutritional habits 
seem to represent the main risk factors for the etiology of 
pandemic obesity.2,6,27 It seems to be the same in Brazil: in 
1997, obesity prevalence was estimated to be 11%,36 while it 
was around 9.6% in 1989, and 5.7% in 1974.5 In 1975, there 
were almost two cases of malnutrition to one of obesity; in 
1997 this situation was the exact opposite. Different from 
other countries, with increasing obesity rates in all social 
levels, low income for the Brazilian population makes it 
more susceptible to obesity.37
Monteiro et al38 evaluated the evolution of obesity in 
Brazil by using data of three national surveys: National 
Survey of Household Expenditure (ENDEF) 1974, National 
Health and Nutrition Survey (PNSN) 1989, and the 
Consumer Expenditure Survey (POF) 2002–2003. In the 
first 14-year period (1975–1989), obesity rates between men 
and women increased 92% and 63%, respectively, and the 
highest rates were found among the low income population. 
In the second 14-year period (1989–2003), there was an 
obesity increase even higher in men and a stabilization of 
this condition in women in general; however among the low 
income women, there was a 26% increase in obesity. Thus, 
Monteiro et al highlighted that the distribution of obesity 
prevalence among the different social classes is especially 
important.
Obesity, hyperlipidic diet and appetite-
regulating hormones
The literature indicates that not only energy intake and energy 
expenditure regulate energy body storage. The balance of 
each nutrient seems to be rigorously controlled to adjust its 
intake to its oxidation (and vice versa), as recently reviewed 
by Pereira-Lancha et al.39
High-fat diets may lead to hyperphagia or cause metabolic 
effects regardless of this condition,40 such as lipolytic activity 
reduction in fat tissue,41 reduction in leptin secretion,42 
and/or limitation of leptin capacity.43 Some studies indicate 
that impairment on mitochondrial metabolism may lead to 
excessive body weight gain when the subjects are fed with 
high-calorie western diets.44 The study of Townsend et al45 
offered two different diets (hyperlipidic and hypolipidic) to 
rats, both diets predominant in saturated fat. The animals 
which consumed a high-fat diet, despite featuring lower total 
energy intake, had increased body fat more than the low-fat 
diet group, and had a higher weight gain even with increased 
leptin levels, pointing to the mechanism of leptin resistance. 
Townsend et al highlighted that the augmentation of caloric 
ingestion is not fundamental to stimulating adiposity increase 
by hyperlipidic diet in rats. Obese individuals feature elevated 
plasma leptin levels, indicating leptin resistance, which may 
be caused by impairment in the leptin binding protein that 
takes leptin to the brain, impairment in the expression and/or 
signaling of the brain leptin receptor, and impairment in the 
leptin synthesis/secretion by adipocytes.46
Other than leptin, signals provided by the gastrointestinal 
tract also have an important role in appetite regulation and 
energy intake (Figure 1); among them are cholecystokinin 
(CCK), glucagon-like peptide 1, pancreatic polypeptide, 
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all of which have a negative effect on energy balance, and 
ghrelin, which has the opposite effect.47
Evidence suggests that the mechanisms inhibiting both 
appetite and caloric ingestion may be impaired in obese 
individuals.48 This is not yet consensual in the literature, 
although many authors have been trying to clarify how 
the mechanisms regulating hunger and satiety behave in the 
obese population.
CCK
CCK is one of the most studied hormones regarding food 
intake regulation. It is largely found in the central nervous 
system and produced by the jejunum and duodenum as food 
enters the intestine, especially protein and fat-rich foods, 
which can increase CCK levels up to five times. When 
administered, CCK can induce satiety and reduce food 
portion sizes both in humans and other species in a dose-
dependent manner.
The mechanisms by which CCK exerts these effects are 
controversial. One of the hypotheses is that CCK inhibits 
gastric peristalsis, mainly by gastric emptying. CCK may also 
act on vagal afferent nerve fibers to induce cardiovascular 
effects and reflex inhibition of splanchnic sympathetic nerve 
discharge.49 It has been well described that adult rats chroni-
cally fed a high-fat diet maintain reduced sensitivity to CCK. 
Swartz et al50 demonstrated that male rat pups fed a high-fat 
diet exhibit reduced sensitivity to CCK; the development of 
this reduced sensitivity is quicker than its extinction when 
the high-fat diet was switched to a low-fat diet.
Peptide YY (PYY)
PYY is secreted by intestine cells after food intake, exerting 
a negative feedback (inhibits food consumption); however, it 
has been demonstrated that in obese individuals, PYY levels 
are lower than in normal people, making this mechanism of 
satiety less efficient in this case.51
Plasma levels of PYY are reduced during a fasted state; 
they increase gradually approximately 15 minutes after meal 
initiation. PYY release peak levels occur 1–2 hours after the 
meal begins and are elevated until 6 hours later. PYY levels are 
dependent on meal macronutrients and calories, and a protein-
rich meal seems to increase PYY levels more than fat-rich 
or carbohydrate-rich isocaloric meals. In addition, the more 
protein that is in a diet, the higher the PYY levels.52 Besides 
nutrients and calories, bile, hydrochloric acid, vasoactive 
intestinal polypeptide, and CCK also enhance PYY release.53 
Studies with PYY administration in humans and animals 
featured both appetite and food intake reduction up to 30% 
for up to 24 hours. This therapeutic effect might be especially 
useful in the treatment of obesity, since obese individuals 
present reduced PYY levels.54 More and more evidence has 
demonstrated that PYY has considerable effect on energy 
expenditure and substrate utilization. Some studies have shown 
that PYY chronic administration alters substrate utilization 
favoring fat oxidation.55 Moreover, overexpressing PYY 
animals feature higher basal temperature, indicating increased 
thermogenesis.56 A study performed with humans comparing 
eutrophic and obese individuals showed that PYY peripheral 
infusion increased energy expenditure and fat oxidation.57
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Figure 1 Evidence suggests that the mechanisms inhibiting both appetite and caloric ingestion may be impaired in obese individuals.48
Note: This is not yet consensual in the literature, although many authors have been trying to clarify how the mechanisms regulating hunger and satiety behave in this population.
Reproduced with the permission of The American Physiological Society from Little TJ, Horowitz M, Feinle-Bisset C. Modulation by high-fat diets of gastrointestinal function 
and hormones associated with the regulation of energy intake: implications for the pathophysiology of obesity. Am J Clin Nutr. 2007;86(3):531–541.
Abbreviations: CCK, cholecystokinin; GLP-1, glucagon-like peptide 1; OXM, oxyntomodulin; PP, pancreatic polypeptide; PYY, peptide YY.
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These data might indicate that the use of this peptide in 
obesity treatment can be very promising.
Ghrelin
On the other hand, ghrelin is synthesized and secreted both 
in the stomach and the intestine, stimulating food intake. 
Its normal levels are usually low after meals; however, in 
obese subjects, ghrelin levels are elevated after food intake, 
stimulating hunger.58 In fact, some studies evidenced 
that obese subjects submitted to weight loss treatment 
demonstrate increased ghrelin levels.59
Ghrelin reaches it maximal plasma levels before meals 
in order to stimulate food intake. After the meal, its levels 
are reduced to its lowest point approximately 60–90 minutes 
later, returning to basal parameters. A new release peak 
occurs a few moments before a new meal.60 Kinetics of 
ghrelin plasma concentrations suggest that it is the signal for 
hunger initiation. Chronic ghrelin administration in rodents 
results in hyperphagia and body weight gain regardless of 
ghrelin-induced growth hormone level increases.
Exercise also regulates ghrelin secretion. A study showing 
the effects of time and intensity of exercise on this parameter 
showed that subjects who cycled for 120 minutes/day 
  consumed significantly more food compared to those who 
trained 30 or 60 minutes/day and to the control group.61
One of the reasons why diet fat may lead to hyperphagia 
also comes from its organoleptical properties,62 such as 
high palatability, characteristic texture,21,63 and large utility 
and versatility as a culinary ingredient.64 A high-fat diet is 
  preferably consumed even by rats when they can choose 
among three different chemically defined diets, each of them 
rich in one of the three primary macronutrients.65
However, a few authors believe that the type of diet fat 
can also influence body fat storage, since there are studies 
showing significant correlation between body fat percentage 
and saturated and monounsaturated diet fat percentage.66 Rats 
submitted to a high-fat diet for 7 weeks (58% total caloric 
intake), rich in saturated fat, developed greater adiposity 
when compared to animals fed with diets rich in omega 3 and 
omega 6 fats and control animals fed with an isocaloric low-
fat diet.67 Matsuo and Suzuki68 demonstrated altered affinities 
of β-adrenergic receptors in brown adipose tissue, the heart, 
and soleus muscle as a consequence of a high-fat diet rich 
in saturated fatty acids. Awad and Zepp69 demonstrated that 
rats fed with a saturated fatty acid-rich diet featured lower 
lipolysis rates than animals fed with a polyunsaturated fatty 
acid-rich diet, due to a lower activity of hormone sensitive 
lipase. Others have also indicated that saturated fatty acid 
intake enhances body fat storage accumulation by a reduction 
of sympathetic activity in brown adipose tissue, the heart, 
and skeletal muscle.68,70
The activity of carnitine-palmitoyltransferase complex 
(CPT-1) and, consequently, β-oxidation in brown adipose 
tissue have also been reported to reduce with the intake of 
saturated fatty acids.71 In fact, mitochondrial membrane 
fluidity, which is determined by a cholesterol/phospholipids 
rate and by the instauration of the fatty acids that constitute 
membrane phospholipids, seems to be directly related to 
CPT-1 activity in the liver.72
Obesity and insulin resistance
Obesity is responsible for triggering a group of metabolic 
disorders with vascular implications named metabolic 
syndrome,73 which is characterized by hyperinsulinemia, high 
levels of glycemia or diabetes, and at least two different levels 
of insulin resistance that explain the relationship between 
various abnormalities and this disease.74
Insulin resistance is defined by reduction of its capacity 
to stimulate glucose utilization,75 either by insulin deficiency 
or by impairment in its secretion and/or utilization.76 There is 
also an intermediate situation between glucose homeostasis 
and diabetes named glucose intolerance or reduced glucose 
tolerance.76
Lipid accumulation in the liver is considered to be one 
of the primary mechanisms relating obesity-related insulin 
resistance and type 2 diabetes. Glucose uptake is reduced 
by insulin resistance in muscle and fat cells, whereas insulin 
resistance in liver cells results in both reduced glycogen 
synthesis and storage and a failure to suppress glucose 
production and release into the blood.77 Abdominal adiposity 
correlates with hepatic glucose production, and it is also 
known that free fatty acid flux is increased in obese subjects 
with upper body adiposity. When free fatty acids are elevated, 
insulin’s ability to suppress hepatic glucose production is 
markedly attenuated, and this effect is most evident in subjects 
with impaired glucose tolerance and type 2 diabetes.77
Although obesity is pointed at as the most common cause 
of insulin resistance, not all obese individuals develop this 
alteration. According to various authors,78–80 what determines 
the occurrence of metabolic dysfunction is the location of 
the accumulation of body fat – mainly visceral adiposity,80 
gender,81 and low physical activity levels.82
It is well established that exercise improves insulin 
sensitivity. Laaksonen et al83 studied 612 men who were 
followed for 4 years. Of these, 107 subjects developed 
metabolic syndrome, 40% of them exercised less than 
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3 hours/week. Other than that, these subjects featured higher 
blood pressure levels, were heavier, and more dyslipidemic 
and hyperinsulinemic than the subjects who did not have 
metabolic syndrome. Laaksonen et al concluded that 
exercise above the American College of Sports Medicine 
recommendations strongly reduced the risk of developing 
metabolic syndrome.
Many studies indicate an augmentation in lipid oxidation 
when caloric expenditure is higher in obese patients with 
high-fat intake and elevated rate of lipolysis, which is directly 
related to body fat storage.84 This preferential free fatty acid 
utilization from triacylglycerol storage as an energy substrate 
would be responsible for reducing glucose mobilization via 
glycogen. This would lead to a negative feedback of muscle 
and liver glycogen upon glycogen synthase activity and, 
consequently, on glycogen storage. Recently, Lancha Jr et al85 
demonstrated the inverse relationship between glycogen con-
tent and glucose uptake, ie, the fed animals featured higher 
glycogen storage and lower glucose uptake whereas the fasted 
animals had the opposite situation. However, currently, the 
mechanisms related to glycogen and glucose transport are 
uncertain; although, some authors believe that glycogen could 
regulate glucose transport by agglutination of glucose trans-
porter type 4 (GLUT4) molecules and further incorporation 
into glycogen complex and enzymes. This results in insulin 
resistance and glucose intolerance; diabetes appears in obese 
patients after a long period of glucose intolerance and when 
glycemia does not return to the basal state, there is insulin 
resistance,86 which leads to hyperinsulinemia.87–89
In rats fed with a high-fat diet, the development of obesity 
has been observed,90–93 as previously stated, as well as a reduc-
tion in systemic, muscle, and adipocyte insulin action.90–95 
Raubenheimer et al96 fed rats with a 45% fat diet for 8 weeks and 
observed an increase in body weight, triacylglycerol levels of 
117%, hyperinsulinemia, and glucose intolerance. Nascimento 
et al97 demonstrated that animals fed with hyperlipidic diets fea-
tured lower phosphorylation of one of the proteins of the insulin 
signaling mechanisms (protein kinase B/Akt), a denotation of 
reduced insulin action, and resistance induced by diet.
High-fat diet intake has been given much attention, 
especially in regards to its effects on insulin action alteration. 
These alterations have already been observed in a very short 
period of time, for example, 7 days,92 10 days,91 3 weeks,98 
and 4 weeks.95 Various studies demonstrated that insulin 
resistance occurs primarily in the liver, in a very short time 
(3 days), followed by insulin action impairment in some 
groups of skeletal muscles.99,100 These effects depend on the 
type of diet fat (amount, size, and number of unsaturations).101 
The prolonged exposition of adipocytes to saturated fatty 
acids has caused insulin resistance in these cells.102 Many 
mechanisms have been proposed to explain the action of 
lipids in gene expression control of both GLUT4 and insulin 
receptors. Tebbey et al103 suggested that arachidonic acid 
(n = 6) reduces the stability of GLUT4 messenger ribonucleic 
acid, lowering their levels rapidly.
According to Duplus et al,104 fatty acid molecules may 
act in various moments of gene transcription. Figure 2 shows 
some possible mechanisms to illustrate this. For example, 
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Figure 2 Postulated mechanisms for fatty acid control of gene transcription.104 The FA per se, FA-CoA, or FA metabolite modulate (±) transcription of a responsive gene, 
encoding a protein involved in FA transport or metabolism, through various non-mutually selective potential mechanisms. Step 1: a signal transduction cascade is initiated to 
induce a covalent modification of a TF, thereby modifying its transcriptional potency. Step 2: the FA itself or its derivative acts as a ligand for a TF, which then can bind DNA 
at a FA response element and activate or repress transcription. Steps 3, 4 and 5: FA can act indirectly via alteration in either TF mRNA stability (Step 3) or gene transcription 
(Step 4), resulting in variations of de novo TF synthesis (Step 5) with an impact on the transcription rate of genes encoding proteins involved in FA transport or metabolism. 
On binding to the eognate response element, TF acts either as a monomer (Step 6), a homodimer, or a heterodimer with TF+, a different TF (Step 7). 
Notes: Reproduced with the permission of the American Society for Biochemistry and Molecular Biology from Duplus E, Glorian M, Forest C. Fatty acid regulation of gene 
transcription. J Biol Chem. 2000;275(40):30749–30752. Copyright © 2000, by the American Society for Biochemistry and Molecular Biology.
Abbreviations: FA, fatty acids; FA-CoA, fatty acyl-CoA; TF, transcription factor.
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fatty acids could initialize a signaling cascade, in a covalent 
way, to modulate the transcription factor. Another possibility 
would be the liaison of fatty acid to the transcription factor 
to activate or inhibit this process. Finally, fatty acids could 
modify messenger ribonucleic acid stability, as stated before, 
and also alter de novo synthesis of the transcription factor, 
altering protein synthesis.
Another hypothesis to explain gene expression modulation 
by hyperlipidic diets is related to nuclear receptors like 
  peroxisome proliferator-activated receptors (PPARs), which 
act like transcription factors. It has been demonstrated 
that PPARs aid glucose uptake regulation via adiponectin, 
a protein expressed mainly by white adipose tissue. Their 
levels are reduced in various types of obesity and insulin 
resistance.79 High-fat diet intake also seems to exert effects 
upon gene expression of PPAR γ coactivator 1α. PPAR γ 
coactivator 1α consists of a PPAR coactivator, and both have 
a strict relationship with adipocyte synthesis and apoptosis 
and with increased insulin sensitivity. Sparks et al’s study105 
demonstrated that after 3 days of diet, animals featured a 
reduction in PPAR γ coactivator 1α gene expression of 
approximately 25%.
Mammalian target cells of rapamycin are possibly 
enrolled in the mechanisms of insulin resistance, as indicated 
by various in vitro studies, through its signaling pathway.106 
Nevertheless, whether this interference is significant or not 
in vivo is still a controversial point. Reynolds et al107 recently 
demonstrated that a hyperlipidic diet rich in saturated fat 
caused insulin resistance in rats. However, this situation 
was not reversed in the presence of rapamycin, a powerful 
and specific mammalian target of rapamycin inhibitor. Thus, 
Reynolds et al concluded that the progression of insulin 
resistance in rats, resulting from a high-fat intake, was not 
dependent on mammalian target of rapamycin activation in 
skeletal muscle.
Adipose tissue is an important source of proinflammatory 
cytokines and adipokines. It is known that subclinical 
inflammation in obese individuals may be a consequence 
of elevated cytokine secretion by adipocytes, contributing 
to the development of metabolic syndrome.80 Adipokines 
and cytokines secreted by white adipose tissue include 
leptin (appetite inhibitor and T cell proliferation modulator); 
adiponectin (potent vascular protector associated to adequate 
glucose uptake, with concentration inversely proportional to 
adiposity);79 resistin (gives resistance to insulin); and tumor 
necrosis factor α (TNF-α; reduces adiponectin production).108 
According to some authors, TNF-α, a transmembrane protein, 
could also explain alterations in gene expression of molecules 
evolved in glucose uptake, mediated or not by insulin, after a 
high-fat diet intake. TNF-α may act on the insulin signaling 
cascade, phosphorilizing insulin receptor substrate 1 serine 
residues, which impairs its binding capacity to the insulin 
receptor and inhibits signal propagation.109
In addition to its effect on the insulin signaling cascade, 
some studies indicated that TNF-α is capable of reducing 
GLUT4 gene expression.110 Jove et al111 studied the effect 
in vitro of saturated fat on TNF-α gene expression and 
verified that there was an augmentation of 2.5 times in 
both gene and protein expression, which was inversely 
correlated to GLUT4 levels and glucose uptake. Borst et al112 
administered an antiTNF-α substance to Sprague Dawley 
rats and verified an increase of more than 60% in muscle 
glucose transport. The high-fat diet utilized in this study 
has already been associated to a TNF-α level increase in 
Wistar rats.113 Thus, it is possible that TNF-α might have 
contributed, at least in part, to the modification of glucose 
tolerance in this study. However many of these hypotheses 
are not demonstrated yet and more studies are necessary to 
completely understand the alterations in gene expression of 
various proteins after high-fat diets.
Many studies have tried to identify the causes of glucose 
uptake alterations due to high-fat diets; nevertheless this issue 
is still controversial. One of the hypotheses is that alteration 
of glucose receptors impair insulin action, mainly by reduc-
tion of GLUT4 activity. For example, Zierath et al114 found 
impairment in GLUT4 activity in muscle tissue after high-fat 
diet consumption in rats.
Interrelations between obesity  
and amino acid metabolism
Some authors believe that amino acids could have important 
implications in insulin postreceptor mechanisms, impairing 
GLUT4 vesicle translocations.115 Lancha Jr116,117 found 
reduced glucose transport in skeletal muscles of Wistar rats 
supplemented with aspartate and asparagine (both 45 mg/kg 
body weight/day) for 5 weeks when compared to the control 
group. Tyrosine kinase is an enzyme responsible for 
structural modifications of insulin receptor substrate 1 during 
the events of the first cell cycle. No alteration in tyrosine 
kinase activity has been found in supplemented rats;116,118 
amino acids may have interfered in any of the numerous 
postreceptor episodes.
An elevated fat intake and low carbohydrate consumption 
found in obese patients may be responsible for elevating free 
fatty acid plasma levels and, consequently, increasing body 
fat storage in adipose tissue.119 Hyperlipidic diets promote 
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an increase of CPT-1 activity in liver and muscle tissue, 
augmenting lipid oxidation.120 According to Liu et al,121 one 
of the factors that increases muscle CPT-1 activity, due to 
high-fat diets rich in unsaturated fatty acids, is the reduction 
of CPT-1 sensitivity to malonyl-coenzyme A (CoA). 
Synthesized from acetyl-CoA carboxylation, malonyl-CoA 
is critical in the regulation of lipid metabolism, providing 
acetyl-activated groups to fatty acid chain synthesis and 
inhibiting CPT-1 and, consequently, β-oxidation. The 
high intake of unsaturated fatty acids would augment 
mitochondrial membrane fluidity, reducing CPT-1 inhibition 
by malonyl-CoA.121 The fatty acid flux increases towards 
mitochondrion and, according to Koves et al,122 is not 
accompanied by complete β-oxidation due to the incapacity 
of the tricarboxylic acid (TCA) cycle to adjust to increased 
oxidative demand. Thus, metabolites would accumulate 
in its interior, leading to mitochondrion stress and insulin 
resistance. Nevertheless, a study conducted by Bruce et al123 
demonstrated that when an overexpression of CPT-1 in 
muscle tissue is produced, impaired insulin sensitivity due 
to a high-fat diet improved. Bruce et al had already found an 
increase in CPT-1 activity, insulin resistance, triacylglycerols, 
and fat storage in cell membranes associated with a high-fat 
diet. According to them, obesity as a consequence of a fat-
rich diet results in an increase of lipids entering the cell with 
a subsequent increase in oxidation. However, an increase 
in fat oxidation is quantitatively lower than lipids entering 
the cell, and results in higher fat deposits in the cell. The 
accumulation of these bioactive lipid molecules as ceramides 
and diacylglycerols might modify lipid characteristics of the 
cell membrane, interfering in insulin action. However, when 
promoting CPT-1 overexpression in muscle tissue, insulin 
resistance was reduced. Thus, Bruce et al suggested that fat 
entering the mitochondrion is more critical in regulating fatty 
acid oxidation than β-oxidation and the TCA cycle.
In line with this, for this process to be triggered and the 
TCA cycle to run normally, there has to be an oxaloacetate 
yield in the same proportion as acetyl-CoA. In regular 
conditions, glycogen is more relevant initially, and plasma 
glucose has a more discrete participation; afterwards, when 
a reduction in the storage occurs, plasma glucose assumes 
this function of oxaloacetate provision by glycolysis and fur-
ther conversion of pyruvate to oxaloacetate.124 Nevertheless, 
when glucose/glycogen concentration is reduced due to 
fasting or low carbohydrate intake, or when resulting from 
insulin resistance for example, oxaloacetate yield becomes 
deficient. Amino acids are processed in muscle in order to 
correct this deficiency; leucine, isoleucine, valine, aspartate, 
and asparagine may be metabolized in muscle tissue to 
generate TCA cycle intermediates (such as succinate and 
oxaloacetate) to maintain its flux. These amino acids donate 
their carbon chains to form intermediates and release 
ammonia in muscle tissue. Table 1 indicates the amino 
acids metabolized directly by muscles, the enzymes respon-
sible for transferring amino groups, and the intermediates   
formed.
As long as the TCA cycle is maintained, there will be 
an increase in citrate levels that will inhibit phospho  fructo-
kinase,124 reducing glucose utilization and, as a consequence, 
glucose uptake. This is one of the hypotheses suggested by 
some authors to explain the reduction in glucose uptake 
and, consequently, insulin resistance. Another possibility 
suggested by Marshall et al,125 among others, to clarify 
insulin resistance in this situation is the glycosylation 
of postinsulin substance receptors due to an increase in 
glucosamine levels, which is a product of the hexosamine 
pathway. In this case, ammonia that is liberated from 
muscle cells by amino acid metabolism would be shifted 
to α-ketoglutarate, which is a TCA cycle intermediate, 
generating glutamate. Glutamate and ammonia would be 
metabolized by glutamine synthase, resulting in glutamine 
synthesis. Glutamine is usually utilized as an energy source 
by the intestine and immune cells. Nevertheless, a high 
glutamine production, as a consequence of the elevated 
TCA cycle activity, would stimulate the hexosamine 
pathway (Figure 3). In this pathway, glutamine and fructose 
6-phosphate generate glucosamine 6-phosphate and other 
products in a reaction catalyzed by glutamine: fructose 
6-phosphate amino transferase.126
The augmentation of amino acid metabolism, which 
generates oxaloacetate and other intermediates to the Krebs 
cycle, implies elevation of the cell oxidative capacity and may 
also provoke other cell structural alterations (Figure 4).127 
Other studies also evidenced structural changes related to 
amino acid supplementation, and the authors justified these 
results as a consequence of an increase cell protein turnover128 
Table 1 Amino acid processes in muscle metabolism and their 
respective enzymes, yielding tricarboxylic acid cycle intermediates
Amino acids Enzymes Intermediates
Aspartate Aspartate aminotransferase Oxaloacetate
Asparagine Asparagine aminotransferase Oxaloacetate
isoleucine Leucine aminotransferase Acetyl-CoA and 
Propionil-CoA
Leucine Leucine aminotransferase Acetyl-CoA
valine valine aminotransferase Succinate
Abbreviation: CoA, coenzyme A.
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and insulin levels, are regulated by body fat stores; these 
hormones modulate central effectors of energy balance 
by regulating central nervous system responses to short-
term meal-related signals.130 In obese individuals, these 
mechanisms are blunted by either genetic or environmental 
reasons, for example, increased efferent parasympathetic 
activity in the endocrine pancreas, mediated by the vagus 
nerve, was observed early in genetically obese rats (fa/fa) 
who received arginine infusion, resulting in higher insulin 
secretion compared to lean animals.131 On the other hand, 
Nogueiras et al132 found that obese mice lost the capacity 
of modulating adipocyte metabolism through glucagon-like 
peptide 1 system, which is one of the functions controlling 
fat deposition, enhancing insulin release, and reducing both 
glucagon levels and gastric emptying via neuroendocrine 
mechanisms.
In general, obese individuals’ diets are characterized by 
excessive caloric ingestion, mainly due to larger protein 
and lipid intake and, proportionally, lower carbohydrate 
ingestion. For this reason, carbohydrate stores may not be 
available to the tissues in the same intensity as the other 
two macronutrients, and the increase in insulin levels 
may be interpreted as an attempt to modulate peripheral 
hormonal responses to augment glucose uptake for the 
central nervous system. For instance, daily fluctuations 
in energy balance (towards a deficit) in premenopausal 
women seem to be the most influent factor in changing 
ovarian estrogen exposure and sex hormone-binding 
CHO
AA
NH3
NH3
Oxaloacetate
Glutamate
Acetyl-CoA
Citrate
Citrate-synthase
Alpha keto glutarate
Glutamine synthetase Hexosamine
pathway
Lipids
Glutamine
Figure 3 Adaptation of muscle metabolism to a high availability of lipids.
Note: Reduced participation of carbohydrates and high amino acid participation in anaplerotic reactions are observed, activating the hexosamine pathway. 
Abbreviations: AA, amino acid; CHO, carbohydrate; CoA, coenzyme A; NH3, ammonia.
Figure  4  Micrograph  of  mitochondrial  impairment  caused  by  aspartate  and 
asparagine supplementation in a rat model.
Notes: The left panel shows the soleus muscle of the sedentary control group 
(15,000×) and the right panel shows the soleus muscle of the supplemented group 
(aspartate and asparagine) (7000×).117
or of mitochondrion calcium flux augmentation due to the 
increase in mitochondrion size and number, which could 
stimulate calcium-dependent proteases.129 However, few 
studies have discussed the relationship between body fat 
accumulation and amino acid metabolism in order to verify 
the possible modifications in amino acid metabolic pathways 
caused by an elevated fat intake.
The central nervous system 
“feeding” hypothesis
One of the hypotheses that can be explained by the reduction 
in glucose utilization as a result of insulin resistance, 
as described above,124 is to ensure glucose availability 
to central nervous system cells. In normal individuals, 
long-term signals of lipid cell metabolism, such as leptin 
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globulin levels, which correlate with a reduction in insulin 
level.133 Maybe the opposite takes place in obese subjects: 
increased insulin levels reduce sex hormone-binding 
globulin levels,134 which are correlated to increased 
abdominal fat and the presence of metabolic alterations 
in men and women.135
Experimental models of obesity
The study of obesity in humans would probably answer 
many questions; however, these kinds of studies have several 
ethical and financial limitations. Experimental studies allow 
a greater quantity of inquiries and results, and feature more 
controlled diet and health conditions where the animals can 
be kept free of pathogens. Although experimental obesity 
models cannot be compared to human obesity models, they 
are of great value in the study of biochemical, physiological, 
and pathological conditions necessary for the accumulation 
of excessive body fat. In the last 20 years, knowledge about 
various factors leading to obesity and its metabolic and 
endocrine consequences has been increasing. Much of this 
was generated by experimental obesity models.136
Many forms of genetically inherited obesity are described 
in the literature.137 Rodents such as Sprague Dawley rats 
are particularly propitious to obesity caused by high-fat 
(cafeteria) diets, due to their polygenic heritage. Some 
authors believe that this is an appropriate and realistic model 
to study human obesity.138,139 However, some alterations found 
in human obesity do not occur in these genetic animal models, 
for example, an increase in fat-free mass and some hormonal 
differences.140 Thus, it is clear that the study of obesity in 
genetically altered animals has several limitations; some 
models can only be used for evaluation of specific obesity 
alterations, but are inappropriate for other investigations.
Other than that, due to the fact that a rapid increase in 
obesity cases worldwide is related to the lack of physical 
activity141,142 and higher food availability and intake,2,142,143 
many studies have been performed using the so-called 
“nongene obesity models” which consist of increasing food 
intake in laboratory animals.144 However, in rodents, for 
example, it is hard to elevate caloric intake spontaneously, 
even when the diet is flavored.
Obesity development is possible though, even without 
a caloric intake increment, because a change in nutrient 
composition or in dietary patterns influences the efficiency 
of food utilization and, consequently, increases fat storage 
per consumed calorie. In practical terms, an increase in diet 
density may result in caloric intake augmentation or a raise 
in caloric ingestion of a determined macronutrient, resulting 
in an increase of body fat. High-carbohydrate diets and/or 
high-fat diets, as well as a cafeteria diet, have also been used 
to develop obesity in rats.
A cafeteria diet consists of fat-rich foods often found in 
coffee shops and supermarkets (eg, cookies, salami, cheese, 
bread) and many experimental studies in rats have used 
this diet protocol. This technique is aimed at mimicking 
the food patterns of modern diets, which consist of many 
cafeteria and fast food meals in experimental conditions, 
characterizing a high-fat diet named “western diet.”2,5,19,21,34 
In fact, some studies demonstrate an increase in fat intake in 
animals fed with this kind of food;137 however, these studies 
have limitations. In a pilot study performed in the authors’ 
laboratory, evaluating and controlling the animal intake of 
different kinds of food was difficult. In the experimental 
group, food intake was extremely heterogeneous and hard to 
evaluate, since 1 day after making the food available to the 
animals in individual cages, it was not possible to separate 
each meal to calculate both their intake in terms of macronu-
trients and the type of fat consumed. This aspect has been the 
object of much controversy, mainly in studies of diet-induced 
thermogenesis.140,145–147
An increase in body fat storage can be attained by 
augmenting diet fat intake; however it is advisable to 
avoid a reduction in protein/energy rate in order to 
avoid the impairment of growth and development of the 
experimental animals. In practical terms, diets containing 
60% of fat and 30% of protein initially used butter and eggs; 
lard and casein have been used more recently in order to 
reduce the cost of food preparation. This composition also 
allows the high intake of saturated fatty acids similar to 
that observed in western diets. The most recent Consumer 
Expenditure Survey published by the Brazilian Institute 
of Statistics and Geography found that lipids contributed 
27.6%, 31.5% of which consisted of saturated fat, to 
household food consumption.148 Results found by the 
authors’ group indicated a high intake of saturated fatty 
acids in the diet of obese women: 62.4% of lipid intake was 
related to saturated fatty acids (unpublished observations), 
which corresponds to 17% of total caloric value. According 
to the American Heart Association,149 fatty acid ingestion 
should not exceed 7% of daily total caloric intake. In an 
attempt to develop experimental models that enable studies 
of obesity and its consequences, this high saturated fat 
intake is interesting, since the contribution of this type of 
fat in the impairment of insulin sensitivity due to obesity 
has been demonstrated.102 This alteration in plasma insulin 
levels seems to be highly related to other associated 
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pathologies, such as hypertension, dyslipidemia,150 and 
atherosclerosis.11
Conclusion
More studies are necessary to elucidate the environmental 
factors and molecular mechanisms that induce obesity, 
especially in Brazil, since the low-income population 
seems to be more vulnerable to this disease and will lead to 
enormous health cost increases in the future.
The link between amino acid metabolism and insulin 
resistance, among others, leads to a fertile field for new 
information on obesity etiology. Experimental models are 
important in obesity research due to more controlled experi-
mental conditions, although care must be taken to extrapolate 
this data to human subjects.
It is crucial to stimulate physical activity and dietary 
pattern change through both education and government 
strategies worldwide.
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